Cite

    Neta Goldschmidt et al.. “Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse.” Leukemia & lymphoma, vol. 60, no. 8, 2019, pp. 1890–1898. http://access.bl.uk/ark:/81055/vdc_100087067640.0x00002d